• No results found

non muscle invasive

Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer

Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer

... Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle- invasive bladder cancer.. chengquan Ma 1.[r] ...

6

Diagnostic accuracy of MRI in differentiating non-muscle invasive from muscle invasive bladder carcinoma taking histopathological staging as a standard

Diagnostic accuracy of MRI in differentiating non-muscle invasive from muscle invasive bladder carcinoma taking histopathological staging as a standard

... called non- invasive. Bladder cancer described as superficial are non-muscle ...the muscle layer, it is called invasive. Invasive cancers are more likely to spread (Van ...

6

Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis

Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis

... Urothelial bladder cancer (UBC) is the 5 th most common solid organ cancer in North America with over 74,000 new cases diagnosed every year in the US alone.(1) UBC is especially prevalent among the elderly with an ...

21

Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ

Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ

... Background and objectives: Among the cancers of the urogenital system, bladder cancer is ranked second both in incidence and mortality, and hence, a more accurate estimate of the prognosis for individual patients with ...

10

Molecular Assessment of Non Muscle Invasive and Muscle Invasive Bladder Tumors: Mapping of Putative Urothelial Stem Cells and Toll Like Receptors (TLR) Signaling

Molecular Assessment of Non Muscle Invasive and Muscle Invasive Bladder Tumors: Mapping of Putative Urothelial Stem Cells and Toll Like Receptors (TLR) Signaling

... the non-muscle and muscle invasive cancer ...the non-muscle invasive cancer group and absent in the muscle invasive cancer ...of non-muscle and ...

13

Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer

Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer

... Objective: To assess the risk factors associated with recurrence, progression and survival in high-risk non-muscle-invasive bladder cancer (NMIBC) patients treated with bacillus Calmet[r] ...

8

Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer

Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer

... Background: This study aims to prospectively evaluate the ability of Neutrophil-to-Lymphocyte ratio (NLR) to forecast recurrence in patients with non-muscle invasive bladder cancer (NMIBC). This is a ...

10

Genomic characterization of high-risk non-muscle invasive bladder cancer

Genomic characterization of high-risk non-muscle invasive bladder cancer

... A limitation of this study was the number of patients included in our analysis. While we were only able to fully compare tumors at diagnosis and progression in eight patients, this is the largest series to date ...

9

Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non muscle invasive bladder cancer: Patients’ and urologic oncologists’ perspectives

Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non muscle invasive bladder cancer: Patients’ and urologic oncologists’ perspectives

... University Health Network Urology-Oncology research team is dedicated towards a better understanding of physician perspectives regarding bladder cancer treatment. As care providers for patients with bladder cancer, your ...

18

The management of BCG failure in non muscle invasive bladder cancer: an update

The management of BCG failure in non muscle invasive bladder cancer: an update

... Up to 40% of patients with non-muscle-invasive bladder cancer (NMIBC) will fail intravesical bacillus Calmette-Guérin (BCG) therapy. There is unfortunately no current gold standard for sal- vage ...

7

Original Article TROP2 is associated with the recurrence of patients with non-muscle invasive bladder cancer

Original Article TROP2 is associated with the recurrence of patients with non-muscle invasive bladder cancer

... as non- muscle invasive bladder cancer (NMIBC), which can be managed with a combination of trans- urethral resection (TUR) and intravesical thera- py [2, ...to muscle-invasive bladder ...

8

Canadian guidelines for treatment of non muscle invasive bladder cancer: a focus on intravesical therapy

Canadian guidelines for treatment of non muscle invasive bladder cancer: a focus on intravesical therapy

... Patients with high-risk NMIBC who fail BCG, the option of radical cystectomy should be recommended and discussed with the patient (Grade B recommendation). Herr and col- leagues compared the outcome of patients with ...

6

Original Article MiR-20a in cell-free urine as a potential diagnostic biomarker for non-muscle invasive bladder cancer: a Chinese population-based study

Original Article MiR-20a in cell-free urine as a potential diagnostic biomarker for non-muscle invasive bladder cancer: a Chinese population-based study

... Abstract: The purpose of this study was to examine urinary microRNA-20a (miR-20a) levels in non-muscle-invasive bladder cancer (NMIBC) and its diagnostic value as a noninvasive biomarker. Eighty ...

8

Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer

Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer

... are non-muscle invasive blad- der cancer (NMIBC), the majority of these NMIBC cases will relapse after curative transurethral resection, and some will progress to muscle invasive ...

6

Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma

Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma

... To determine if COX-2 overexpression could be caus- ally related to recurrence of superficial UBC the present study was designed with pathologically homogenous group of solitary papillary non-muscle ...

8

The application of adjuvant autologous antravesical macrophage cell therapy vs  BCG in non muscle invasive bladder cancer: a multicenter, randomized trial

The application of adjuvant autologous antravesical macrophage cell therapy vs BCG in non muscle invasive bladder cancer: a multicenter, randomized trial

... No previous larger data on the use of MAKs exist. The application of viable MAK may trigger various immuno- logical reactions and imply essential systemic risks elu- sive to smaller series. Thus following the phase I ...

6

Prognostic Value of Sex Hormone Receptor Expression in Non Muscle Invasive Bladder Cancer

Prognostic Value of Sex Hormone Receptor Expression in Non Muscle Invasive Bladder Cancer

... Purpose: We investigated sex-hormone receptor expression as predicting factor of recurrence and progression in patients with non-muscle invasive bladder cancer. Ma- terials and Methods: We ...

8

Clinical rationale and safety of restaging transurethral resection in indication stratified patients with high risk non muscle invasive bladder cancer

Clinical rationale and safety of restaging transurethral resection in indication stratified patients with high risk non muscle invasive bladder cancer

... detrusor muscle is lacking in an initial ...no muscle layer in the specimen and after incomplete initial TURBT ...of muscle in speci- men without evidence of T1 or HG has been questioned as ...

6

Role of first check cystoscopy in non-muscle invasive bladder carcinoma: A prospective and historical cohort study

Role of first check cystoscopy in non-muscle invasive bladder carcinoma: A prospective and historical cohort study

... George Farrow, beginning in 1976, defined micro invasive carcinoma as a tumour invading up to 5mm into the lamina propria. After multiple studies the criteria for micro invasion has been refined. The current ...

123

Prognostic Factors for Recurrence and Progression in Korean Non Muscle Invasive Bladder Cancer Patients: A Retrospective, Multi Institutional Study

Prognostic Factors for Recurrence and Progression in Korean Non Muscle Invasive Bladder Cancer Patients: A Retrospective, Multi Institutional Study

... vs. non-papillary), tumor multiplicity (single ...and muscle layer in the specimen were also identified from pathologic ...of muscle invasive disease (≥T2) or metastatic disease at the time of ...

10

Show all 10000 documents...

Related subjects